Adenosine receptors and their ligands

被引:283
作者
Klotz, KN [1 ]
机构
[1] Univ Wurzburg, Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany
关键词
adenosine; adenosine receptors; agonist; antagonist; selectivity; high affinity; A1 center dot A(2A) center dot A(2B); A3; ligand; radioligand; human;
D O I
10.1007/s002100000315
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The regulatory actions of adenosine are mediated via four subtypes of G protein-coupled receptors distinguished as A(1), A(2A), A(2B) and A(3) receptors. Their presence on basically every cell makes them an interesting target for the pharmacological intervention in many pathophysiological situations. A large number of ligands have been synthesized over the last two decades and provide agonists and antagonists that are more or less selective for the known receptor subtypes. In addition, many radioligands are available in tritiated or radioiodinated form. The comparative pharmacological characterization of all four human adenosine receptor subtypes revealed that some of the compounds thought to be selective from data in other species have unexpected potencies at human receptors. As a result, compounds that exhibit high affinity to only one subtype are an exception. Although the selection of ligands is immense, it is less than satisfying for most subtypes of adenosine receptors.
引用
收藏
页码:382 / 391
页数:10
相关论文
共 67 条
[11]   Adenosine A2B receptors:: a novel therapeutic target in asthma? [J].
Feoktistov, I ;
Polosa, R ;
Holgate, ST ;
Biaggioni, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (04) :148-153
[12]   ADENOSINE-A1-RECEPTORS IN MAMMALIAN BRAIN - SPECIES-DIFFERENCES IN THEIR INTERACTIONS WITH AGONISTS AND ANTAGONISTS [J].
FERKANY, JW ;
VALENTINE, HL ;
STONE, GA ;
WILLIAMS, M .
DRUG DEVELOPMENT RESEARCH, 1986, 9 (02) :85-93
[13]  
FREDHOLM BB, 1994, PHARMACOL REV, V46, P143
[14]  
Fredholm BB, 1999, PHARMACOL REV, V51, P83
[15]  
FREDHOLM BB, 2000, NAUNYNSCHMIEDEBERGS
[16]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF N-6-BENZYLADENOSINE-5'-URONAMIDES AS A(3)-SELECTIVE ADENOSINE AGONISTS [J].
GALLORODRIGUEZ, C ;
JI, XD ;
MELMAN, N ;
SIEGMAN, BD ;
SANDERS, LH ;
ORLINA, J ;
FISCHER, B ;
PU, QL ;
OLAH, ME ;
VANGALEN, PJM ;
STILES, GL ;
JACOBSON, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (05) :636-646
[17]  
HUTCHISON AJ, 1989, J PHARMACOL EXP THER, V251, P47
[18]  
Jacobson Kenneth A., 1995, Drugs of the Future, V20, P689
[19]  
JARVIS MF, 1989, J PHARMACOL EXP THER, V251, P888
[20]  
Ji X D, 1999, Drug Des Discov, V16, P217